We are live on ! Find out more
PODD icon

Insulet

623 hedge funds and large institutions have $16.5B invested in Insulet in 2024 Q3 according to their latest regulatory filings, with 91 funds opening new positions, 224 increasing their positions, 237 reducing their positions, and 63 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more first-time investments, than exits

New positions opened: 91 | Existing positions closed: 63

17% more capital invested

Capital invested by funds: $14.1B → $16.5B (+$2.37B)

4% more funds holding

Funds holding: 599623 (+24)

1.12% more ownership

Funds ownership: 99.92%101.04% (+1.1%)

5% less repeat investments, than reductions

Existing positions increased: 224 | Existing positions reduced: 237

29% less call options, than puts

Call options by funds: $163M | Put options by funds: $228M

75% less funds holding in top 10

Funds holding in top 10: 82 (-6)

Holders
623
Holders Change
+24
Holders Change %
+4.01%
% of All Funds
8.93%
Holding in Top 10
2
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-75%
% of All Funds
0.03%
New
91
Increased
224
Reduced
237
Closed
63
Calls
$163M
Puts
$228M
Net Calls
-$65.9M
Net Calls Change
+$22.1M

PODD Hedge Fund Activity: Q3 2024 in Review

623 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q3 2024, worth a combined $16.5B — up 17% from $14.1B a quarter earlier.

Buyers outnumbered sellers: 91 funds opened new PODD positions and 63 closed out — a net gain of 28 holders — while 224 added to existing stakes and 237 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $414M. The largest seller was Wellington Management Group, cutting an estimated $143M.

  • 623 institutional investors held Insulet (PODD) as of Q3 2024, up from 599 in Q2 2024.
  • Funds reported $16.5B of Insulet stock for Q3 2024, up 17% quarter-over-quarter.
  • 91 funds opened new Insulet positions in Q3 2024 and 63 closed out, a net change of +28 holders.
  • The largest Insulet buyer in Q3 2024 was Fidelity Investments, an estimated $414M added.
  • The largest Insulet seller in Q3 2024 was Wellington Management Group, an estimated $143M sold.

Based on aggregated 13F filings for Q3 2024.